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Myocardial Fatty Acid Oxidation: Saturated
Versus Unsaturated
Michael A. Solomon, F. Mark H. Jeffrey, Charles J. Storey, Craig R. Malloy.
University of TX Southwestern Medical Center, Dallas, 7X
Mixture
Saturated
Unsaturated
Fatty acid
1917-931
Fatty acid (FA) metabolism is an integral part of myocardial cellular
metabolism and has been studied in normal, ischemic, post-ischemic, and
hibernating myocardium with Positron Emission Tomography and carbon-14
methods. These tracer studies generally follow only the saturated (S) FA,
palmitate. Human plasma contains a mixture of unsaturated (unS) and SFAs
in a 1.3: 1 ratio. It remains unclear if the oxidation of palmitate is representa-
tive of a biological mixture of FAs. The purpose of this study was to determine
if oxidation of SFAs or unSFAs is similar to a biological mixture.
Methods: Working rat hearts were supplied with carbon-13 enriched lac-
tate (8 mM) in addition to FA (0.27 mM) as either SFA, unSFA or a biologi-
cal mixture. The FAs studied (palmitic[16:0I, palmitoleic[16:1). stearic[18:0],
0Ieic[18:1). Iinoleic[18:2)) constitute >85% of the FAs found in plasma.
The mixture consisted of all 5 FAs in their relative proportions in human
plasma. Carbon-13 Magnetic Resonance Spectroscopy and isotopomer anal-
ysis were used to determine the contribution of each substrate to the acetyl-
CoA pool. The results were analyzed using ANOVA and Student-Newman-
Keuls tests.
Results: The type of FA used did not significantly alter CO or RPP The
oxidation of unSFAs was significantly less than the oxidation of SFAs or the
biological mixture of FAs.
*p < 005
Conclusions: Under these conditions saturated FAs are preferred for oxi-
dation compared to unsaturated FAs. The oxidation of palmitate or stearate
appears representative of a biological mixture
The recent findings that lipid lowering therapy reduces clinical events to a
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Monocyte migration into the vessel wall is an early step in atherogenesis.
A number of chemotactic factors for monocytes have been identified, The
regulation of the chemotactic response, however, is only poorly understood.
We studied the influence of low density lipoprotein (LDL) on chemotactic
mobility to a standardized stimulus, Migration of human monocytoid U937
cells was abolished by 30 h incubation in medium with 10% Iipoprotein-
deficient-serum. Human LDL, VLDL. HDL. or free cholesterol (5-20 j.Lg/mll
were added for 0.5-12 h. At the end of each incubation period, chemotaxis
to 1% human serum (modified Boyden chamber). viability (dye exclusion),
and cellular cholesterol content (high performance thin layer chromatogra-
phy) were measured. In the same experimental setting the effects of the
pharmacological agents chloroquine (60 j.LMl. indomethacin (20 j.Lg/ml). or
acetylsalicylic acid (ASS, 100 j.LM) on LDL mediated chemotaxis were stud-
ied. In some experiments the effect of fatty acids (linoleic acid, arachidonic
acid, 10 j.LM for 2 hours) on restoration of chemotaxis was investigated.
Chemotaxis was restored by LDL in a time and dose dependent manner
starting at concentrations as low as 5 j.Lg/ml and incubation periods of 30
minutes. Free cholesterol, VLDL, or HDL had no such effect on chemotaxis.
Viability and total cholesterol was not different in all groups. Simultaneous
incubation of cells with chloroquine, indomethacin or ASS reduced restitu-
tion of chemotaxis by LDL by 71 %, 82% or 68% respectively. In contrast.
the agents had only slight inhibitory effects on chemotactic mobility of con-
trol cells which were serum fed. Incubation with linoleic acid showed 60%
restoration of chemotaxis, whereas arachidonic acid stimulated chemotaxis
response to 140% of positive control.
Conclusion: The data are consistent with a novel cyclooxygenase depen-
dent regulation of chemotaxis by LDL.
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Recombinant Endotoxin-binding Protein (rBPI23)
Attenuates Endotoxin-induced Circulatory
Changes in Humans
Lipoprotein(a) Assayed from Frozen Serum
Degrades with Time in Storage
Tilt CPT AN PE Tilt
ILl.SBPI ILl.SBP) (Slope) (Slope) (Ll.NE)
1 OH-BRD -63 ± 21* 22 ± 9* 0.0 ± 06*t 0.4 ± 1't 154±216
2.0H-NBR -36 ± 11 t 34 ± 10 3.8 ± 24 8.8 ± 3 284 ± 170
3. NL-NBR -6± 8 29 ± 15 4.2 ± 29 7.5 ± 7 246 ± 189
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The protective effect of rBPI 23 on the circulatory changes induced byexperi-
mental endotoxemia in humans was tested in a controlled blinded crossover
study. Eight healthy male volunteers were challenged twice with an intra-
venous bolus injection of endotoxin (40 EUlkgl and concurrently received ei-
ther rBPI 23 (1 mg/kg) or placebo. Hemodynamic parameters were obtained
non-invasively over a period of twelve hours by means of M-mode-, Two-
dimensional- and Doppler Echocardiography. Blood Pressure was recorded
using a Dynamap. rBPln significantly reduced endotoxin-induced increase
in Heartrate (85 ± 5 versus 67 ± 5 Beat/min, P = 00078). Cardiac Index
(3.98 ± 0.25 versus 3.28 ± 0.27 Llmin/m2, P = 00156). and Maximal Ve-
locity in the Left Ventricular Outflow Tract (1.26 ± 0.07 versus 1.09 ± 0.05
m/sec, P < 0.05). rBPI23 diminished the endotoxin-induced decrease in Sys-
temic Vascular Resistance (1633 ± 79 versus 2051 ± 134 dyne*sec/cm-5, P
= 0.0304). rBPI23 did not prevent the endotoxin-induced rise in Body Tem-
perature (+ 1.9°C) and Systolic, Diastolic and Mean Arterial Blood Pressure
were comparable in the rBP123- and placebo-treatment arm. Both treatment
periods showed a small reduction in End-SystOlic and End-Diastolic Volumes
as measured by M-mode. Circulatory changes induced by endotoxin lasted
for 12 hours, The protective effect of rBPI23 was maximal between 1:30 and
4:00 hours after the start of the endotoxin infusion.
Conclusion: These results indicate that rBPI23 is capable of attenuating
the circulatory effects of endotoxin in humans.
Sarah M. Vernon, Ian J. Sarembock, Carlos R. Ayers, Eric R. Powers, Lawrence
W Gimple. University of Virginia, Charlottesville, VA
Although we have previously identified a strong correlation between lipopro-
tein(a) (Lp(a)) concentrations measured from fresh serum and restenosis af-
ter balloon angioplasty (PTCA), the relationship between Lp(al and resteno-
sis remains controversial. In previous studies reporting a lack of corre-
lation between Lp(a) concentration and restenosis, serum samples were
frozen for prolonged periods prior to assay, and the reported concentra-
tions of Lp(a) were lower than in studies reporting a positive correlation
between Lp(al and restenosis, We hypothesized that this may be due to
degradation of Lp(a) occurring during storage. Accordingly, we measured
Lp(a) concentrations (monoclonal/polyclonal sandwich enzyme immunoas-
say, MACRA Lp(a)) from serum samples of patients undergoing PTCA Re-
peated freeze/thaw cycles (_70°) without storage did not result in Lp(al
degradation. In group 1 patients (n = 10), mean Lp(a) concentrations de-
creased significantly after 18 months of storage at _70° (30 ± 24 vs 6.8
± 6.8, P = 0.007). In group 2 patients (n = 6), serum samples previously
frozen and stored for 18 months demonstrated continued degradation after
a subsequent 9 months of storage (48 ± 19 vs 33 ± 15, P = 0.00021. In con-
clusion, we observed that Lp(a) degrades significantly during storage, even
when samples remain frozen at _70°. This observation may explain inconsis-
tencies in results of previously published studies examining the relationship
between Lp(a) and restenosis, and casts doubt upon studies measuring Lp(a)
concentrations from stored samples.
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Conclusions: (1) Patients with idiopathic BRD present with OH, have at-
tenuated response to CPT and normal catecholamine response to tilt. (2)
OH-BRD and BRF are two different syndromes with different etiologies and
clinical manifestations; however, both have BR abnormalities.
